An implant is a man-made medical device which replaces, supports or enhances a missing, damaged, or existing biological structure, by inserting into the human body cavity. Bio-implants are the prostheses used for regularizing the physiological functions of an individual. Injectable bio-implants are non-surgical treatment options that offer effective restoration, replacement, or modulation of damaged, deregulated or lost physiology. The global continuous increase in life expectancy and decrease in mortality rate have resulted in greater proportion of people aged above 60 years. Geriatric population is growing at a rate higher than any other age group worldwide. This population demands effective, fast and safe treatment for age-related conditions. This has grabbed the attention of non-surgical bio-implants manufacturer to invest into this market and also key players are taking efforts to develop and commercialize cost effective implants which will fulfill demand of geriatric population.
Non-Surgical Bio-Implants Market: Drivers and Restraints
Rising geriatric population, growing concern for chronic diseases, high level of healthcare awareness, and growing disposable incomes are the major drivers for the growth of non-surgical bio-implants market. In addition, rising application areas mainly medical and aesthetic for biomaterials used in non-surgical bio-implants will accentuate the market growth. In future, technological advancement in bio-implants is expected to have a strong growth in this market. However, bio incompatibility, high treatment cost, time consuming approval processes of implants by regulatory authorities, and reimbursement issues would hinder the growth of non-surgical bio-implants market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1316
Non-Surgical Bio-Implants Market: Segmentation
The global non-surgical bio-implants market is segmented based on types of non-surgical bio-implants, injectable biomaterials used in bio-implants.
- Non-surgical bio-implants
- Viscoaugmentation bio-implants
- Viscosupplementation bio-implants
- Injectable biomaterials
- Alloplastic biomaterials
- Acrylic hydrogel
Non-Surgical Bio-Implants Market: Market Overview
By non-surgical bio-implants type, viscoaugmentation and viscosupplementation are the choice of bio-implants among the relatively limited non-surgical bio-implants that are approved in the market. By Injectable biomaterials type, collagen based bio-implants holds prominent share owing to its lower cost and easy availability. Hyaluronan are also commonly used bio-implants with various applications in all areas, like surgical, orthopedic, cosmetics and medical applications.
Non-Surgical Bio-Implants Market: Region-wise Outlook
North America region has the largest market for non-surgical bio-implants, in terms of revenue due to large number of key players and strong healthcare infrastructure. Europe region is the second largest non-surgical bio-implants market due to technological advancement in the region. In addition, high disposable income and increase in geriatric population in developing countries like India and China, are expected to drive the growth non-surgical bio-implants market in Asia.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1316
Non-Surgical Bio-Implants Market: Key players
Key companies operational in non-surgical bio-implants market are Albiorex International, FibroGen, Inc., Kythera Pharmaceuticals, Inc., Moma Therapeutics, Inc., Novatex Bioengineering SA, Anika Therapeutics, Inc., Johnson & Johnson, Fidia Farmaceutici, LCA Pharmaceuticals, Hangzhou Gallop Biological Products Co. Ltd., and others.
Future Market Insights
616 Corporate Way,
New York 10989,